These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30630693)

  • 41. [Inactivated poliovirus vaccine].
    Shimizu H
    Nihon Rinsho; 2011 Sep; 69(9):1604-8. PubMed ID: 21922761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of provocation poliomyelitis in vaccine-associated poliomyelitis.
    Ehrengut W
    Acta Paediatr Jpn; 1997 Dec; 39(6):658-62. PubMed ID: 9447753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.
    Anand A; Zaman K; Estívariz CF; Yunus M; Gary HE; Weldon WC; Bari TI; Steven Oberste M; Wassilak SG; Luby SP; Heffelfinger JD; Pallansch MA
    Vaccine; 2015 Nov; 33(48):6816-22. PubMed ID: 26476367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1999 Jan; 103(1):171-2. PubMed ID: 9917460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Halpern MS; Altamirano J; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E; Sherrod JL
    J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
    Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
    Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Economic impact of introducing the injectable inactivated polio vaccine in Colombia].
    Alvis N; De la Hoz F; Narváez J
    Rev Panam Salud Publica; 2010 May; 27(5):352-9. PubMed ID: 20602069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS; Greening G; Baker MG; Grimwood K; Hewitt J; Hulston D; van Duin L; Fitzsimons A; Garrett N; Graham D; Lennon D; Shimizu H; Miyamura T; Pallansch MA
    Lancet; 2005 Jul 30-Aug 5; 366(9483):394-6. PubMed ID: 16054940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
    N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.
    Ion-Nedelcu N; Strebel PM; Toma F; Biberi-Moroeanu S; Combiescu M; Persu A; Aubert-Combiescu A; Plotkin SA; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S241-6. PubMed ID: 9203723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.